Oversight of 340B, as Measured by Audits/Audit Findings, Is Woefully Lagging, New Analysis Finds

And the latest skirmish in the pharm-to-table trend underscores the choice that telehealth providers must make around obesity meds

Brian Reid

Jun 23, 2025